IP Library › Patent Application 12274867
Patent Application
App. No. 12/274,867

Method for the Treatment of Multiple Sclerosis by Inhibiting IL-17 Activity

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
12/274,867
Abstract

Provided are methods of treatment for inflammatory and autoimmune disorders of the central nervous system and gastrointestinal tract. Also provided are methods of diagnosis.

Claims (5)

1 - 20 . (canceled)

21 . A method for treatment of multiple sclerosis (MS) comprising administering to a patient a therapeutically effective amount of an anti-IL-17 antibody or an anti-IL-17 antibody fragment.

22 . The method according to claim 21 wherein the antibody or antibody fragment is monoclonal, polyclonal, or humanized.

23 . The method according to claim 21 wherein the antibody fragment is a Fab, Fv, F(ab′) 2 fragment or antigen binding fragment.

24 . The method according to claim 21 wherein the anti-IL-17 antibody or anti-IL-17 antibody fragment is administered in combination with one or more other therapeutically active compounds.